Inventor · disambiguated record
Craig M. Crews
Also filed as: CREWS CRAIG · CREWS CRAIG M
33 granted patents·39 pending applications·1,127 citations·filing 2000–2025
98Inventor score
Top patents by PatentIndex Score
72 records- 0198US7232818B2Compounds for enzyme inhibitionPROTEOLIX INC·Filed 2005·Granted Jun 19, 2007·88 cites·50 claims
- 0297US10730870B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS INC·Filed 2016·Granted Aug 4, 2020·25 cites·22 claims
- 0397US9758522B2Hydrophobically tagged small molecules as inducers of protein degradationDANA FARBER CANCER INST INC·Filed 2013·Granted Sep 12, 2017·27 cites·22 claims
- 0497US7491704B2Compounds for enzyme inhibitionPROTEOLIX INC·Filed 2007·Granted Feb 17, 2009·57 cites·48 claims
- 0596US10772962B2Compounds and methods for the targeted degradation of bromodomain-containing proteinsARVINAS INC·Filed 2016·Granted Sep 15, 2020·15 cites·23 claims
- 0696US8324174B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2011·Granted Dec 4, 2012·28 cites·27 claims
- 0796US8129346B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2005·Granted Mar 6, 2012·38 cites·62 claims
- 0896US7041298B2Proteolysis targeting chimeric pharmaceuticalUNIV CALIFORNIA·Filed 2001·Granted May 9, 2006·177 cites·4 claims
- 0996US6831099B1Enzyme inhibitionUNIV YALE·Filed 2000·Granted Dec 14, 2004·109 cites·21 claims
- 1095US10723717B2Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptidesARVINAS INC·Filed 2017·Granted Jul 28, 2020·16 cites·44 claims
- 1195US9938264B2Proteolysis targeting chimera compounds and methods of preparing and using sameUNIV YALE·Filed 2016·Granted Apr 10, 2018·33 cites·20 claims
- 1295US9632089B2Small-molecule hydrophobic tagging of fusion proteins and induced degradation of sameUNIV YALE·Filed 2016·Granted Apr 25, 2017·113 cites·7 claims
- 1395US8088741B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2005·Granted Jan 3, 2012·43 cites·20 claims
- 1493US10145848B2Small-molecule hydrophobic tagging of fusion proteins and induced degradation of sameUNIV YALE·Filed 2017·Granted Dec 4, 2018·9 cites·6 claims
- 1593US9500653B2Small-molecule hydrophobic tagging of fusion proteins and induced degradation of sameCREWS CRAIG M·Filed 2011·Granted Nov 22, 2016·116 cites·5 claims
- 1693US7208157B2Proteolysis targeting chimeric pharmaceuticalUNIV CALIFORNIA·Filed 2002·Granted Apr 24, 2007·185 cites·9 claims
- 1792USRE48175EHydrophobically tagged small molecules as inducers of protein degradationDANA-FARBER CANCER INSTITUTE INC·Filed 2013·Granted Aug 25, 2020·9 cites·25 claims
- 1892US10071164B2Estrogen-related receptor alpha based protac compounds and associated methods of useUNIV YALE·Filed 2015·Granted Sep 11, 2018·8 cites·9 claims
- 1991US10730862B2Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligaseUNIV YALE·Filed 2013·Granted Aug 4, 2020·15 cites·14 claims
- 2089US2025034096A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 2188US11220515B2Imide-based modulators of proteolysis and associated methods of useUNIV YALE·Filed 2019·Granted Jan 11, 2022·5 cites·16 claims
- 2287US10604506B2Modulators of estrogen receptor proteolysis and associated methods of useARVINAS INC·Filed 2018·Granted Mar 31, 2020·3 cites·20 claims
- 2386US10994015B2EGFR proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2017·Granted May 4, 2021·3 cites·25 claims
- 2485US2025228944A1Compounds and methods for the targeted degradation of bromodomain-containing proteinsARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 2584US11512083B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2020·Granted Nov 29, 2022·1 cites·17 claims
- 2682US2025223265A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 2781US11028088B2Modulators of BTK proteolysis and methods of useUNIV YALE·Filed 2019·Granted Jun 8, 2021·2 cites·35 claims
- 2880US12171831B2Compounds and methods for the targeted degradation of bromodomain- containing proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Dec 24, 2024·0 cites·14 claims
- 2979US12239711B2Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2022·Granted Mar 4, 2025·0 cites·1 claims
- 3079US2024382599A1Egfr proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 3178US12264157B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Apr 1, 2025·0 cites·24 claims
- 3278US10806737B2Compounds and methods for the targeted degradation of fetal liver kinase polypeptidesARVINAS OPERATIONS INC·Filed 2017·Granted Oct 20, 2020·2 cites·23 claims
- 3377US2025360219A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 3476US2024059686A1Compounds and methods for the targeted degradation of the androgen receptorARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 3574US2024299366A1Imide-based modulators of proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2023·Application pending·0 cites
- 3674US2024317729A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2024·Application pending·0 cites
- 3773US12275716B2Modulators of estrogen receptor proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2022·Granted Apr 15, 2025·0 cites·16 claims
- 3872US2024368179A1Imide-based modulators of proteolysis and methods of useUNIV YALE·Filed 2023·Application pending·0 cites
- 3970US11834460B2Imide-based modulators of proteolysis and associated methods of useUNIV YALE·Filed 2021·Granted Dec 5, 2023·0 cites·20 claims
- 4069US11554171B2Compounds and methods for the targeted degradation of bromodomain-containing proteinsARVINAS OPERATIONS INC·Filed 2020·Granted Jan 17, 2023·0 cites·16 claims
- 4168US2020155690A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 4268US2020155689A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 4367US2021220475A1Egfr proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 4466US11986531B2Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptidesARVINAS OPERATIONS INC·Filed 2021·Granted May 21, 2024·0 cites·19 claims
- 4565US2018228907A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS INC·Filed 2018·Application pending·0 cites
- 4665US2022089570A1Imide-based modulators of proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 4764US7476650B2Enzyme inhibitionUNIV YALE·Filed 2004·Granted Jan 13, 2009·0 cites·10 claims
- 4864US2013324459A1Compounds For Enzyme InhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4963US2020325130A1Proteolysis Targeting Chimera Compounds and Methods of Preparing and Using SameUNIV YALE·Filed 2020·Application pending·0 cites
- 5063US2018354954A9Hydrophobically tagged small molecules as inducers of protein degradationDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →